« Previous
Next »
Lung Cancer
Volume 65, Issue 2
, Pages
192-197
, August 2009
Phase II study of ASA404 (vadimezan, 5,6-dimethylxanthenone-4-acetic acid/DMXAA) 1800
mg/m2 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer
To access this article, please choose from the options below
PII: S0169-5002(09)00206-2
doi: 10.1016/j.lungcan.2009.03.027
© 2009 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Lung Cancer
Volume 65, Issue 2
, Pages
192-197
, August 2009
